1. Home
  2. HVT vs NGNE Comparison

HVT vs NGNE Comparison

Compare HVT & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Haverty Furniture Companies Inc.

HVT

Haverty Furniture Companies Inc.

HOLD

Current Price

$20.79

Market Cap

336.7M

ML Signal

HOLD

Logo Neurogene Inc.

NGNE

Neurogene Inc.

HOLD

Current Price

$30.17

Market Cap

327.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HVT
NGNE
Founded
1885
2003
Country
United States
United States
Employees
2392
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
336.7M
327.8M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
HVT
NGNE
Price
$20.79
$30.17
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$63.57
AVG Volume (30 Days)
68.3K
151.5K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
6.05%
N/A
EPS Growth
N/A
0.93
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.83
N/A
Revenue Next Year
$8.70
N/A
P/E Ratio
$22.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.32
$14.65
52 Week High
$27.67
$37.27

Technical Indicators

Market Signals
Indicator
HVT
NGNE
Relative Strength Index (RSI) 42.15 58.76
Support Level $20.07 $18.25
Resistance Level $21.45 $32.02
Average True Range (ATR) 1.03 2.31
MACD -0.11 0.00
Stochastic Oscillator 25.70 56.20

Price Performance

Historical Comparison
HVT
NGNE

About HVT Haverty Furniture Companies Inc.

Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of revenue from its upholstery products and, secondarily, from bedroom furniture.

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

Share on Social Networks: